Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products > Novel inhibitors

Novel inhibitors

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC3129 Lp-922761
Novel potent and selective peripheral AAK1 inhibitor
More description
DCC3128 Lp-261
Potent antimitotic and oral tubulin binding agent, significantly inhibiting growth of a human non-small-cell lung tumor
More description
DCC3127 Lp-20 Hydrochloride
Potent ligand of the 5-HT7 receptor
More description
DCC3126 Lox-activity Sensor-1
Novel LOX-activity sensor for cross-linking with a collagen peptide to chemoselectively target endogenous aldehydes generated by LOX
More description
DCC3125 Lopinavir M-3/m-4
Lopinavir Secondary Metabolite
More description
DCC3124 Loperamide
Opioid receptor agonist, acting on the µ-opioid receptors in the myenteric plexus of the large intestine
More description
DCC3123 Longanlactone
Natural neurotrophic agent
More description
DCC3122 Lomefloxacin
Antibiotic for treatment of bacterial infections including bronchitis and urinary tract infections, prevent urinary tract infections prior to surgery
More description
DCC3121 Lobelane Hydrochloride
Inhibitor of the Vesicular_monoamine_transporter_2>vesicular monoamine transporter-2 (VMAT2)
More description
DCC3119 Lnp599 Hydrochloride
Novel potent and specific agonist of I 1 imidazoline receptors
More description
DCC3118 lnp-509
Potent and selective ligand of imidazoline 1 receptor (I 1 R)
More description
DCC3117 Ln3844
Novel Two-in-One Mutant-Selective Epidermal Growth Factor Receptor Inhibitor That Spans the Orthosteric and Allosteric Sites
More description
DCC3116 Lmptp-in-5d
Novel highly selective inhibitor of the low-molecular-weight protein tyrosine phosphatase (LMPTP), being highly orally bioavailable and reversing obesity-induced diabetes in mice
More description
DCC3115 lmc-21
Novel AI-2 quorum-sensing inhibitor, affecting the starvation response and reducing virulence in several Vibrio species, most likely by interfering with LuxPQ
More description
DCC3114 lm-24 Hydrochloride
Novel p75NTR antagonist
More description
DCC3113 Lm229
Novel Probe for Imaging Tau Pathology in Transgenic Mouse and Rat Models
More description
DCC3112 lm11a-36
Negative control for LM11A-24
More description
DCC3111 lm11a-24
Novel Modulator of p75NTR-dependent motor neuron death
More description
DCC3110 Lm-030
Novel inhibitor of kallikrein-related peptidase 7 (KLK7) and epidermal elastase 2 (ELA2)
More description
DCC3109 Ll4212
Novel inducer of biofilm dispersal, having a slower rate of NO release
More description
DCC3107 lk 204-545
DCC3106 Ljp-1586
Potent, selective, and orally active inhibitor of semicarbazide-sensitive amine oxidase (SSAO) activity, inhibiting vascular adhesion protein 1 (VAP-1) activity and decreasing the density of macrophages in inflamed atherosclerotic plaques in mice
More description
DCC3105 Lith-o-asp
Novel pan-inhibitor of sialyltransferase (ST)
More description
DCC3104 lisa-4
The first fluorogenic dipeptide probe for
More description
DCC3103 Lipocrine
The first inhibitor of the catalytic activity of AChE and AChE-induced amyloid-beta aggregation protecting against reactive oxygen species
More description
DCC3102 Lipid Ii Binder 5107930
Lipid II binder, causing specific upregulation of the vancomycin-resistance associated gene vraX which is implicated in the cell wall stress stimulon that confers glycopeptide resistance
More description
DCC3101 Lintopride
5HT-4 antagonist with moderate 5HT-3 antagonist properties
More description
DCC3100 Linker-payload 49
Novel Fused Benzodiazepine Hybrid Payload for Antibody-Drug Conjugate (ADC)
More description
DCC3099 Linifolin A
Natural capsid inhibitor
More description
DCC3098 Lin28-let-7 Inhibitor-1
Novel inhibitor of the oncogenic Lin28-let-7 interaction
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X